Position in NVS
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$548,363
+$13,891 QoQ
Shares Held
3,499
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#848
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Newman Dignan & Sheerar, Inc. holds $16,082,023 across 8 Drug Manufacturers - General names. NVS ranks #7 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
21,236 | $5,393,306 | |
| 2 | MRK |
Merck & Co., Inc.
|
28,738 | $3,692,833 | |
| 3 | AMGN |
Amgen Inc
|
7,582 | $2,745,593 | |
| 4 | LLY |
ELI LILLY & Co
|
1,043 | $1,251,005 | |
| 5 | ABBV |
AbbVie Inc.
|
4,147 | $1,043,551 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
17,344 | $999,361 | |
| 7 | NVS |
Novartis AG
This page
|
3,499 | $548,363 | |
| 8 | PFE |
Pfizer Inc
|
16,944 | $408,011 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $548,363 | 3,499 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $534,472 | 3,499 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $482,407 | 3,499 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $448,711 | 3,499 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $447,615 | 3,699 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $412,364 | 3,699 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $359,949 | 3,699 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $425,458 | 3,699 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $393,795 | 3,699 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $357,804 | 3,699 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $373,488 | 3,699 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $376,780 | 3,699 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $373,266 | 3,699 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $340,308 | 3,699 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $335,573 | 3,699 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $281,160 | 3,699 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $312,676 | 3,699 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $324,587 | 3,699 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $323,551 | 3,699 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $305,775 | 3,739 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $341,146 | 3,739 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $319,609 | 3,739 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $353,073 | 3,739 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $350,187 | 4,027 | Shares | Sole | 2020-10-14 | |
| 2020-06-30 | $351,718 | 4,027 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $332,026 | 4,027 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||